Stocks To Buy Now

Blog

The Stocks To Buy Now Blog

Our team has been covering the micro- and small-cap markets for more than a decade, exploring a wide variety of trends, technology and news in every industry. The Stocks to Buy Now blog seeks out undervalued companies, covers their news, breaks down the jargon, and delivers accurate and timely information to you on a daily basis.

If you’re looking for market insight, undervalued gems, and an assortment of investment options, read on.

Laguna Blends, Inc. (LAGBF) Proposes Non-Brokered Private Placement

Earlier this week, Laguna Blends, Inc. (CSE: LAG) (OTC: LAGBF) announced plans to complete a non-brokered private placement of 1,863,636 units priced at $0.11 for gross proceeds of $205,000. Each unit will include one share of the company’s Canadian Securities Exchange common stock, as well as one transferable share purchase warrant exercisable at $0.15 for […]

Giggles N’ Hugs, Inc. (GIGL) is an Expansion-Ready Model with a Pitch-Perfect Mix of Offerings for the Kid-Friendly Dining/Play Center Market

Giggles N’ Hugs (OTCQB: GIGL) combines a fresh and healthy menu, replete with great-tasting and refined dishes that appeal to discerning adults, as well as kid-friendly selections that boast numerous organic features (http://dtn.fm/v45Ge) (like being gluten-free and made from locally-grown ingredients) that you simply won’t find in other so-called kid-friendly restaurants – with a highly […]

Moxian, Inc. (MOXC) Redefining Business Marketing, Strategy by Strategy

Moxian, Inc. (OTCQB: MOXC) exists for the e-commerce operator, software developer, manufacturer, payment provider and other merchants who wish to promote their businesses using novel social marketing techniques. The company continually redefines marketing with precision. After a timely entrance into the online-to-offline market in Asia, it has steadily developed its social marketing and promotional platforms […]

Immune Therapeutics, Inc. (IMUN) Enters Binding Letter of Intent to Acquire Innovative CAR-T Cell Technology

Before the opening bell, Immune Therapeutics, Inc. (OTCQB: IMUN) announced its entry into a binding letter of intent to acquire Chinese Chimeric Super Antigen Receptor T cell (CAR-T) cocktail therapy, pending immuno-oncology patents, manufacturing technology and clinical data regarding the aforementioned therapies from Super-T Cell Cancer Company (STCC), a newly-formed corporation. The technology outlined in […]

Star Mountain Resources, Inc. (SMRS) Well-Positioned To Profit from Projected Zinc Shortage via Low-Cost Balmat Mine in Upstate New York

With numerous pundits currently raving about the bullish undercurrent for zinc, as a looming supply shortfall is predicted on the horizon amid ebbing China slowdown fears, it makes a great deal of sense to look at domestic producers in low-risk jurisdictions. Producers who can act as a profit vehicle for investors over the medium- to […]

 

From Our Blog

SuperCom Ltd. (NASDAQ: SPCB) Expands Wisconsin Footprint with Third County Deployment, Highlighting Rapid EM Scaling Model

February 5, 2026

SuperCom (NASDAQ: SPCB), a global provider of secured e-Government, IoT, and cybersecurity solutions, is extending its electronic monitoring footprint in the U.S. Midwest, announcing a third county-level deployment in Wisconsin just months after entering the state. The latest project, disclosed on February 2, represents the company’s fifth new EM launch since the beginning of the […]

Rotate your device 90° to view site.